BOND™ - DNA Negative Control is intended for use in the - LEICA BIOSYSTEMS NEWCASTLE LTD

Duns Number:397134693

Device Description: DNA Negative Control is intended for use in the identification of background staining resu DNA Negative Control is intended for use in the identification of background staining resulting from non-specific interactions in formalinfixed,paraffin-embedded tissue by in situ hybridization (ISH) using the automated BOND system (includes Leica BOND-MAX systemand Leica BOND-III system).

Want to know more about this Product? Request more information now!


More Product Details

Catalog Number

PB0731

Brand Name

BOND™

Version/Model Number

PB0731

Device Commercial Distribution Status

In Commercial Distribution

Commercial Distribution End Date

-

Issuing Agency

In GS1

Product Characteristics

MRI safety Status

Labeling does not contain MRI Safety Information

Device required to be labeled as containing natural rubber latex or dry natural rubber (21 CFR 801.437)

-

Device labeled as "Not made with natural rubber latex"

-

For Single-Use

-

Prescription Use (Rx)

Yes

Over the Counter (OTC)

-

Kit

-

Combination Product

-

Human Cell, Tissue or Cellular or Tissue-Based Product (HCT/P)

-

FDA Premarket Submission

-

Product Code Details

Product Code

MVU

Product Code Name

Reagents, Specific, Analyte

Device Record Status

Public Device Record Key

704e15ff-00dc-431b-bc4a-91d7b373cda3

Public Version Date

March 29, 2021

Public Version Number

1

DI Record Publish Date

March 19, 2021

Additional Identifiers

Package DI Number

None

Quantity per Package

-

Contains DI Package

-

Package Discontinue Date

-

Package Status

-

Package Type

-

"LEICA BIOSYSTEMS NEWCASTLE LTD" Characteristics
Device Class Device Class Description No of Devices
1 A medical device with low to moderate risk that requires general controls 365
2 A medical device with a moderate to high risk that requires special controls. 7
3 A medical device with high risk that requires premarket approval 1